Skip to main content
Clinical Trials/KCT0006413
KCT0006413
Withdrawn
未知

Effects of Hyperbaric Oxygen Therapy on Erectile function and Lower Urinary Tract Symptoms(LUTS) in Patients with Chronic Erectile Dysfunction and/or LUTS

Myongji Hospital0 sites130 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the genitourinary system
Sponsor
Myongji Hospital
Enrollment
130
Status
Withdrawn
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • A. Among patients who visit our hyperbaric oxygen treatment center for hyperbaric oxygen therapy, those with erectile dysfunction and/or lower urinary tract symptoms who agree to participate in this study
  • \* Inclusion criteria
  • ? Men with erectile dysfunction 50 years of age or older who have had sexual intercourse at least once in the past month and have a regular sexual partner (male sexual function questionnaire: IIEF\-5 less than 22 points)
  • ? Men 50 years of age or older with lower urinary tract symptoms (International Prostate Symptom Score: IPSS \>8\) (with or without symptoms of overactive bladder or erectile dysfunction)
  • ? Women over 40 years of age with lower urinary tract symptoms (International Prostate Symptom Score: IPSS \>8\) (with or without symptoms of overactive bladder)
  • B. Patients over 20 years of age diagnosed with interstitial cystitis and consenting to participate in this study
  • ? Adults with age of 20 years old or above.
  • ? Patients with symptoms of unpleasant sensation (pain, pressure, and discomfort) perceived to be related to the urinary bladder, associated with lower urinary tract symptoms of more than 6 months duration, in the absence of infection or other identifiable causes.
  • ? Patients have received cystoscopy and ruled out other bladder lesion.
  • ? Free of active urinary tract infection (UTI).

Exclusion Criteria

  • \-Erectile dysfunction Exclusion criteria
  • 1\. a history of pelvic surgery
  • 2\. unstable medical or psychiatric disorders, neurological diseases other than diabetic neuropathy, chronic haematological diseases, or penile anatomical abnormalities and nonresponders to PDE5I
  • 3\. uncontroled DM, chr. heart, kidney, or liver dysfunction
  • 4\. Peyronie’s disease; systemic anticoagulation; uncontrolled hypertension or hypotension; severe vision loss or retinitis pigmentosa
  • 5\. trauma or surgery on the spinal cord or brain. significant cardiovascular disease within the past 3 months, hypogonadism, hyperprolactinemia, chronic prostatitis, chronic intake of central nervous system or antiandrogen drugs any fibrotic anomalies in the penis
  • 6\. untreated endocrinologic disease (including normal testosterone levels)\-thyroid disease, dysfunction
  • 7\. participant’s inability to fully comply with study protocol
  • \-Lower Urinary Tract Syndrom(Male) Exclusion criteria
  • 1\. evidence of prostate cancer, previous prostatic surgery, history of AUR within 3 mo prior to study entry

Outcomes

Primary Outcomes

Not specified

Similar Trials